CACO-2 permeability assay help determine the absorption rate, which is the compound's bioavailability, and helps predict the absorption during in vivo studies. Our ADME services team determines the absorption of the New Chemical Entity (NCE) by dosing it on Colon Carcinoma Cells (CACO-2).
Our CACO-2 assay is a monolayer membrane that can be tailored to your requirements and meet regulatory requirements. We can also help our clients understand unidirectional and bi-direction permeability.
Aurigene Pharmaceutical Services is
that provides contract research and manufacturing services
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.